Medicinal product name Fulvestrant Mylan
Pharmaceutical form Solution for injection
Strength 250 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L02BA03 Endocrine therapy

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(250 mg/5 ml)
Glass pre-filled syringe 180.50  EU/1/17/1253/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/17/1253/001
Date of authorisation Jan 8, 2018
Marketing authorisation holder, country Mylan Pharmaceuticals Limited, Ireland